A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study. [electronic resource]
Producer: 20120521Description: 643-9 p. digitalISSN:- 1573-7373
- Adolescent
- Antineoplastic Agents -- therapeutic use
- Brain Stem Neoplasms -- drug therapy
- Child
- Child, Preschool
- DNA Modification Methylases -- metabolism
- DNA Repair Enzymes -- metabolism
- Dacarbazine -- analogs & derivatives
- Drug Therapy, Combination -- methods
- Female
- Glioma -- drug therapy
- Guanine -- analogs & derivatives
- Humans
- Kaplan-Meier Estimate
- Ki-67 Antigen -- metabolism
- Male
- Proportional Hazards Models
- Retrospective Studies
- Temozolomide
- Tumor Suppressor Proteins -- metabolism
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.